drugset
drugset / Trial / NCT01869985

Partial Replicated Crossover Clinical Study to Compare Pharmacokinectic Characteristics of Eperisone Hydrochloride and Aceclofenac With HCP1104 Treatment to Those of Co-administration of Eperisone Hydrochloride 50mg Tablet and Aceclofenac 100mg Tablet in Healthy Adult Male Volunteers

NCT01869985 ↗

Phase 1 Completed 30 enrolled Hanmi Pharmaceutical Company Limited
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to evaluate pharmacokinetics and safety after oral administration of HCP1104 and Eperisone Hydrochloride plus Aceclofenac.

Timeline

Start
2013-08
Primary completion
2013-09
Completion
2014-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Aceclofenac Small molecule 100 mg Oral
Subject Eperisone Small molecule 50 mg Oral
Subject HCP1104 Unknown — Oral

Indications

No indication recorded.